BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

Free Newsletters
My Subscriptions

News by Subject
News by Disease
News by Date
Search News
Post Your News

Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Pharm Country
  Bio NC
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™


Company Profiles

Research Store

Research Events
Post an Event
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile


Hospira, Inc. 

275 North Field Drive
Lake Forest  Illinois  60045  U.S.A.
Phone: 224-212-2000 Fax: n/a


Hospira is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness™ by developing, manufacturing and marketing products that improve the productivity, safety and efficacy of patient care. Created from the core global hospital products business of Abbott Laboratories in April 2004, Hospira has a 70-year history of service to the hospital industry.

In February 2007, Hospira acquired MaynePharma Limited to become the world leader in specialty generic injectable pharmaceuticals. Through its offering of high-quality, lower-cost alternatives to proprietary medications, Hospira continues to help reduce the overall costs of healthcare – to improve both the affordability of care for patients and the financial strength of the global healthcare system. The company also is a pioneer in providing innovative solutions to improve patient and healthcare worker safety. Its portfolio includes one of the industry's broadest lines of generic acutecare and oncology injectables, and integrated solutions for medication management and infusion therapy.

Nine manufacturing facilities in the United States include: Ashland, Ohio; Austin, Texas; Boulder, Colo.; Buffalo, N.Y.; Clayton, N.C.; McPherson, Kan.; Morgan Hill, Calif.; Rocky Mount, N.C. Nine facilities outside the United States include: Aguadilla, Puerto Rico; Haina, Dominican Republic; La Aurora de Heredia, Costa Rica; Liscate, Italy; Montreal, Canada; Mulgrave, Australia; Salisbury, Australia; Sligo, Ireland; and Wasserburg, Germany.

• John C. Staley, Chairman of the Board of Directors
• Mike Ball, Chief Executive Officer (CEO)

Hospira has established long-standing customer relationships that span the "continuum of care" (hospitals, alternate site facilities, home healthcare providers and long-term care facilities).

Hospira has a leading position in the manufacture and supply of a broad range of hospital products including:

• Specialtyinjectables (including generic acute-care and oncology injectables, intensive-care proprietary pharmaceuticals, as well as proprietary delivery systems such as the iSecure™ syringe, a pre-filled, ready-to-use, disposable syringe)
• Medication management systems (including electronic infusion pumps and the HospiraMedNet® software system)
• Infusion therapy solutions/supplies (including the VisIV™ next-generation container)
• Critical care devices
• Third-party contract manufacturing, which leverages Hospira's expertise in pharmaceutical manufacturing

Hospira's news releases and other information can be found at

 Key Statistics

Ownership: Public

Web Site: Hospira, Inc.
Employees: Approximately 15,000 employees worldwide


 Company News
Hospira, Inc. Receives FDA Clearance For Plum 360™ Infusion System 1/20/2015 10:30:29 AM
Hospira, Inc. to Shutter Plant, 250 Workers Affected 1/14/2015 6:29:57 AM
Hospira, Inc. Submits New Biologics License Application To U.S. FDA For Proposed Epoetin Alfa Biosimilar 1/12/2015 8:45:01 AM
FDA Lifts Import Ban on Hospira, Inc.'s Infusion Pumps 1/8/2015 8:47:04 AM
Hospira, Inc. Receives U.S. FDA Approval Of Proprietary Analgesic Dyloject™(diclofenac sodium) Injection 12/30/2014 7:22:48 AM
Hospira, Inc. Announces Voluntary Worldwide Recall Of 10 Lots Of Mitoxantrone Due To Confirmed Subpotency And Out-Of-Specification Impurities 12/24/2014 7:01:19 AM
Hospira, Inc. To Present At The J.P. Morgan 33rd Annual Healthcare Conference Jan. 14, 2015 12/22/2014 8:38:12 AM
Hospira, Inc. Mourns Passing of Founding Board Member Dr. Connie R. Curran 11/17/2014 3:15:37 PM
Hospira, Inc. Announces U.S. Launch of Generic Paricalcitol Injection 11/6/2014 7:36:38 AM
Hospira, Inc. Hit With Another Serious Infusion Pump Recall 11/6/2014 7:14:21 AM